Pre-Revenue Stocks

Showing 942 articles
Business

Carnival Stock: A Deep Value Play After Debt Pivot and Travel Rebound?

Carnival Corporation's shares have surged over three years, yet a detailed financial analysis suggests the cruise giant may still be trading at a significant discount. As the industry navigates post-pandemic recovery and debt reduction, investors are weighing if the current price reflects underlying value or lingering risks.

Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.

Business

Foraco International's Surging Profitability Catches Investor Attention

The drilling services firm Foraco International (TSE:FAR) is demonstrating a powerful trend of improving capital efficiency, with its Return on Capital Employed (ROCE) jumping 53% over five years. This signals a company that's generating significantly more profit from each dollar invested, a key marker often sought by long-term investors.